Stern Advice: When advisers follow the crowd Reuters

New Post Public Reply Private Reply Replies (1) Message Board
goarmy123 MaxShockeR #47

Stern Advice: When advisers follow the crowd

By Linda Stern

WASHINGTON (Reuters) - Three years after a market rout sent investors scurrying in every direction but Wall Street, some financial advisers are tentatively starting to put their clients back into stocks, according to recent reports.

"Gun-shy advisers tiptoe back into equities," read one of these stories, here at Reuters ( http://link.reuters.com/nag96s). The gist of it was that investors, who had been afraid to invest in stocks since the market tanked in 2008, were coming back now that shares were rising briskly. And their advisers were accommodating them.

That seems like particularly bad timing on the part of the experts. Since the market bottomed three years ago this week, the Dow Jones Industrial Average has gone up roughly 100 percent. And now they're tiptoeing back.

It used to be that one of the main benefits offered by advisers was their calming presence when clients were panicking, according to Louis Harvey, president of Dalbar, a research firm that monitors investment behavior. He said that clients got better about not panicking and so advisers aren't so needed now for their hand holding and countervailing advices.

But during the last three years, terrified investors have been bringing their apocalyptic visions to advisers. And, instead of quoting Baron "Buy when blood is running in the streets" Rothschild or even hanging tough, too many advisers just gave clients what they said they wanted. They have been moving clients into bonds, selling them guaranteed annuities, and doing other things to make sure those doors are locked tight, well after that horse has bolted.

"The dash to Treasuries since 2008, and the move out of stocks after stocks were just hacked to pieces was an amazing mistake," says David Dreman, a well-known contrarian investment manager and author of "Contrarian Investment Strategies: The Psychological Edge."

Dreman, who claims to have profited greatly by buying beaten down stocks in 2008 and 2009, charges that most paid advisers don't have the fortitude to buck the trends. "Investment advisers tend to run with the market, so if the market is down, they'll run down; if it's up, they'll run in late."

Harvey suggests that maybe Dreman and I are being a little bit unfair to advisers. The credit and stock market meltdown of 2008 and 2009 was so extreme "the entire investment community had no idea what to do," he says. "You're talking about the most unusual period I've ever seen."

Maybe so, but Harvey's own research shows that individual investors allow their mood swings and fears to cut their investment earnings. Why pay an adviser big bucks to do the same?

Here are some thoughts about being contrarian.

-- It helps to watch values. Price-to-earnings ratios, price-to-book value ratios and the like are a good way to tell how fairly priced the market is. At the peak of the dot-com frenzy in 2000, the Nasdaq PE/ratio was around 200. Yikes! A more typical PE ratio for the Dow Jones industrial average is between 15 and 18; right now it's slightly above 14.

"When it gets up to 22 or 23 or 24, that means the market is overvalued as a whole," says Dreman. "Even for a company with tremendous promise, I would never pay much more than 20 or 25 times earnings."

-- It's probably not too late. Maybe those advisers tiptoeing into stocks now haven't completely missed the party, because valuations are nowhere near bubble-like levels. Dreman believes there are still bargains to be had in stocks and that we are in for a long bull. "We're closer to 'the world is coming to an end' extreme than the overvalued extreme," he says. "The Standard and Poor's 500 stock index is selling around 13 times earnings right now; that's well below average."

-- Avoid hyperbolic advisers. A real red light is an adviser who tells you that "this time it's different" or "stocks will never be what they were before" or "this one's going through the roof."

-- Avoid advisers who won't challenge you. If you go to an adviser and say you're scared, or excited, or ambitious, and she pulls out a product just for that situation, that's probably not going to be a great fit. A really good adviser takes in all of your concerns and then figures out what's best for you long term, given your financial situation and the economic situation. She doesn't just sell to your moods.

-- Don't try to catch every wave. Contrarian investing is a long-term approach, but not one that you can be on top of every minute. If a stock that you really like falls, and you're on top of the reasons why, you may be able to pick up a bargain. But if the market is experiencing high volatility and seems to be getting whipsawed by rapid automated trading, you can get burned buying or selling. By the time you enter your trade, the price may have moved beyond your target and you'll end up buying too high or selling too low.

-- Listen to your adviser. Ask a lot of questions about his investment philosophy. Find out where he was putting money in 2009 and 2010 and 2011. If he didn't do anything you couldn't have done on your own, then maybe you don't need the help.

(The Stern Advice column appears weekly, and at additional times as warranted. Linda Stern can be reached at linda.stern@thomsonreuters.com; She tweets at http://www.twitter.com/lindastern; Read more of her work at http://blogs.reuters.com/linda-stern; Editing by Steve Orlofsky)

(Cohttp://finance.yahoo.com/news/stern-advice-advisers-crowd-131950090.htmlrrects spelling to Dreman (from Dremen) in paragraphs 6-8, 12-13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 115

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 163

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 104

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 98

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 89

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

SPHEREboard 6.11 Launch Enhances Identity Security Solutions

Updated Category News Views 153

SPHEREboard 6.11 Launch Elevates Identity Intelligence SPHERE, a frontrunner in Identity Intelligence, has recently accomplished two major milestones that are set to reshape identity security: the launch of SPHEREboard 6.11 and the formation of a dedicated Board of Advisors. These initiatives reflect SPHERE's unwavering commitment to not only enhancing identity hygiene...

Continue Reading
Edible Garden Expands Organic Herb Offerings in New Jersey

Updated Category News Views 127

Edible Garden Launches Organic Herb Line in Local Supermarkets Exciting news for herb enthusiasts! Edible Garden AG Incorporated, a leader in controlled environment agriculture, has announced the launch of its USDA Organic herb product line at select supermarkets in New Jersey. These include Superfresh, City Supermarket, and Fine Fare Supermarkets. Distinct Offerings from...

Continue Reading
Strengthening Cybersecurity: The Evolving Role of CISOs

Updated Category News Views 48

Cybersecurity in Today's Business Landscape As organizations navigate through the constantly changing threat landscape, cybersecurity has emerged as a crucial element of strategic business frameworks. Companies are increasingly recognizing the significance of enhancing their security postures, prioritizing the role of Chief Information Security Officers (CISOs), and...

Continue Reading
Qnity Takes Major Steps With Form 10 Registration Announcement

Updated Category News Views 232

Qnity Celebrates Effective Form 10 Registration Statement In a recent development that emphasizes growth, Qnity is thrilled to announce the effectiveness of its Form 10 registration statement. This milestone is crucial for Qnity as it advances its strategies while aligning with DuPont de Nemours, Inc. (NYSE: DD). The registration is a significant step towards enhancing...

Continue Reading
Important Position Disclosure by Rathbones Group Plc

Updated Category News Views 119

Overview of the Disclosure Process Understanding the dynamics of stock market dealings is crucial for every investor. Rathbones Group Plc plays a significant role in this context, especially when it comes to complying with regulatory frameworks. One such requirement is the public disclosure related to significant ownership positions in relevant securities, particularly...

Continue Reading